Clinical Trial Update: Metabolic Phenotypes and Heterogeneity in Disease Burden Risk in Type 1 Diabetes

View source ↗

Summary

A completed clinical trial exploring metabolic phenotypes and heterogeneity in disease burden risk in individuals with Type 1 diabetes mellitus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Snippet

Sponsor: University of Michigan | Conditions: Diabetes Mellitus | Status: COMPLETED